As decentralized trials reduce face time with participants, sponsor organizations that treat engagement as an afterthought will pay for it in dropout rates, missing data and failed endpoints.
The post Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier appeared first on MedCity News.
